Innoventric
Pioneering transcatheter technology for tricuspid regurgitation with a novel cross-caval approach.
About
Innoventric is a medical device company specializing in a novel transcatheter cross-caval approach for treating tricuspid regurgitation (TR). Their Unicaâ„¢ implant offers a simple, anatomy-agnostic solution designed for safe and effective TR treatment, aiming to expand care to a broader patient population. The company is focused on advancing this technology through clinical trials and has secured significant funding to support its development. Teams look it up for Healthcare, Medical Devices, Cardiology.
Frequently asked
What does Innoventric do?
Innoventric is a Healthcare company that offers Hardware. Teams look it up for Medical Devices, Cardiology, Innovation. It is based in San Jose, United States and was founded in 2016. Public records show about 23 people and $29M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Innoventric raised?
Innoventric has raised a total of $29M in funding. The most recent round on record is Series B.
Where is Innoventric headquartered?
Innoventric is headquartered in San Jose, United States.
When was Innoventric founded?
Innoventric was founded in 2016.
What industry does Innoventric operate in?
Innoventric operates in Healthcare, Medical Devices, Cardiology, Innovation, Biotechnology.
How many employees does Innoventric have?
Innoventric has approximately 23 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.